从世界范围来看，多数国家对基础研究的资助体系都采用“竞争性项目制+稳定的机构式资助”的双轨模式，但不同国家各有侧重。荷兰、德国、法国等欧洲国家以机构式资助为主，美国和中国的体制比较像，以竞争性项目为主，不过大部分科研人员能获得一份“有市场竞争力”的薪酬并由政府兜底，与项目关系不大。多位专家还注意到，近年来，各国都存在逐渐强调竞争性资助，弱化稳定资助的趋势。

zhongyaocaishizhenggezhongyaoshengchandeyuantou。zhongyaocaijikejingguofuzashengchangongyi，beizhijiezhichengzhongchengyao，yekebeijiagongchengzhongyaoyinpian，zhongyaoyinpianshilinchuangtangjihezhongchengyaoshengchandeyuanliao，haikebeijiagongchengzhongyaocaitiquwu，zaijinyibuzhichengpeifangkelihuozhongchengyao。zhongyaocaiyinpian、peifangkeli、zhongchengyaojunkeyouzhongyaocaixiaoshougongsi、liansuoyaodianjiyiyuandengjinxingxiaoshou，gegehuanjie，xianghuyingxiang，youxianghuguanlian。中(zhong)药(yao)材(cai)是(shi)整(zheng)个(ge)中(zhong)药(yao)生(sheng)产(chan)的(de)源(yuan)头(tou)。(。)中(zhong)药(yao)材(cai)既(ji)可(ke)经(jing)过(guo)复(fu)杂(za)生(sheng)产(chan)工(gong)艺(yi)，(，)被(bei)直(zhi)接(jie)制(zhi)成(cheng)中(zhong)成(cheng)药(yao)，(，)也(ye)可(ke)被(bei)加(jia)工(gong)成(cheng)中(zhong)药(yao)饮(yin)片(pian)，(，)中(zhong)药(yao)饮(yin)片(pian)是(shi)临(lin)床(chuang)汤(tang)剂(ji)和(he)中(zhong)成(cheng)药(yao)生(sheng)产(chan)的(de)原(yuan)料(liao)，(，)还(hai)可(ke)被(bei)加(jia)工(gong)成(cheng)中(zhong)药(yao)材(cai)提(ti)取(qu)物(wu)，(，)再(zai)进(jin)一(yi)步(bu)制(zhi)成(cheng)配(pei)方(fang)颗(ke)粒(li)或(huo)中(zhong)成(cheng)药(yao)。(。)中(zhong)药(yao)材(cai)饮(yin)片(pian)、(、)配(pei)方(fang)颗(ke)粒(li)、(、)中(zhong)成(cheng)药(yao)均(jun)可(ke)由(you)中(zhong)药(yao)材(cai)销(xiao)售(shou)公(gong)司(si)、(、)连(lian)锁(suo)药(yao)店(dian)及(ji)医(yi)院(yuan)等(deng)进(jin)行(xing)销(xiao)售(shou)，(，)各(ge)个(ge)环(huan)节(jie)，(，)相(xiang)互(hu)影(ying)响(xiang)，(，)又(you)相(xiang)互(hu)关(guan)联(lian)。(。)